应对碘海醇短缺的短期、中期和长期策略
本文针对近期碘海醇短缺导致全球碘对比剂供应中断、放射科无法为需增强检查患者提供医疗服务的问题,提出短期(数周)、中期(数月)和长期(数年)应对策略,并讨论影响放射科供应链问题的长期议题与潜在解决方案。
要点
- 碘海醇短缺造成放射科无法为需增强检查的患者提供医疗服务。
- 短缺影响分短期(数周)、中期(数月)和长期(数年)三个时间尺度。
- 报告提供近期应对短缺的策略并讨论长期供应链问题与潜在解决方案。
核心结论
- 报告提供应对碘海醇短缺的近期策略,并讨论影响放射科供应链问题的长期议题与潜在解决方案。
研究设计与样本
- 本文为报告,旨在提供应对近期短缺的策略并讨论长期供应链问题与潜在解决方案。
临床应用与阅片要点
- 放射科可参考本文提供的短期(数周)、中期(数月)和长期(数年)策略应对碘海醇及后续碘对比剂短缺。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The recent iohexol shortage has precipitated disruptions in a pharmaceutical supply chain critical to radiologic imaging and has impacted global availability of iodinated contrast media (ICM). The shortage has created a national crisis in radiology departments, curtailing their ability to provide health care to patients who need contrast-enhanced examinations. Radiology departments are familiar with crisis management after more than 2 years of clinical and operational disruptions associated with the COVID-19 pandemic. The iohexol and subsequent ICM shortage has short-term (weeks), midterm (months), and long-term (years) implications. The purpose of this report is to provide strategies for dealing with the shortage in the near term and to discuss long-term issues and potential solutions to supply chain problems impacting radiology departments.
引用
- Grist, Canon, Fishman, et al. Short-, Mid-, and Long-term Strategies to Manage the Shortage of Iohexol. Radiology. 2022. PMID: 35587228. doi:10.1148/radiol.221183
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。